Pharma Veterans

Controversies – Drug Pricing in Pakistan – Asrar Qureshi’s Blog Post #863 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #863 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Credit: Nataliya Viatkevich Credit: Polina Tankilevitch Credit: Anna Shvets Drug Pricing Policy 2018, which is the most recent and current policy for regulating drug prices, stipulated that the pharma companies would be able to increase prices every year automatically, based on inflation data – CPI, issued by the government and as provided in the policy. However, in early 2019, DRAP amended the policy unilaterally to take back its control over drug pricing. This was done after public outcry over price increases and ongoing debate about affordable healthcare. Kabeer...

Encouraging Bad and Expecting Good – Asrar Qureshi’s Blog Post #841 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #841 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Mikhail Nilov Photo Credit: Markus Spiske Photo Credit: Asad Photo Maldives Photo Credit: Atta Putta Gunawan James Heskett is UPS Foundation Professor Emeritus at the Harvard Business School. He is a regular contributor to HBS Working Knowledge, and his articles are always deeply thought provoking. Primary thought for this post comes from his August 2023 article titled ‘As Leaders, Why Do We Continue to Reward A, While Hoping for B?’. ( Link at the end ). His article focuses on corporates, which I shall take up in the next post with particular reference to ...